Filter
1705
Filtered Results: 1705
Text search:
CD4
Featured
Recommendations
119
New Publications
457
Language
Document type
No document type
1208
Guidelines
228
Studies & Reports
140
Manuals
43
Fact sheets
30
Training Material
23
Strategic & Response Plan
20
Infographics
8
Brochures
3
Situation Updates
1
Resource Platforms
1
Countries / Regions
India
90
South Africa
53
Kenya
50
Tanzania
48
Latin America and the Carribbean
40
Zambia
35
Malawi
31
Paraguay
31
Uganda
30
Rwanda
27
Ethiopia
26
Nepal
25
Senegal
25
Ukraine
24
Western and Central Europe
24
Nigeria
22
Lesotho
21
Global
21
Russia
21
Namibia
21
Mozambique
20
Africa
20
Argentina
20
Eastern Europe
19
Zimbabwe
18
Indonesia
18
Asia
17
Brazil
16
Congo, Democratic Republic of
15
Cambodia
14
Venezuela
14
Colombia
12
Ghana
12
Liberia
11
Myanmar / Burma
11
Sierra Leone
10
Albania
9
Burkina Faso
9
Germany
9
Botswana
9
Haiti
8
Bolivia
8
Benin
7
Cameroon
7
Philippines
7
Bangladesh
7
Ecuador
7
Peru
6
Madagascar
6
Eswatini/ Swaziland
6
Tajikistan
5
Armenia
5
South–East Asia Region
5
Georgia
5
El Salvador
4
North America
4
Central African Republic
4
Estonia
3
Middle East and North Africa
3
East and Southern Africa
3
Vietnam
3
Moldova
3
Angola
3
Pakistan
3
North Macedonia
2
Thailand
2
Kazakhstan
2
Chile
2
Syria
2
Afghanistan
2
Guinea
2
USA
2
West and Central Africa
2
Southern Africa
2
Sudan
2
Yemen
2
Romania
2
South Sudan
2
Gambia
1
Laos
1
Niger
1
Uzbekistan
1
Italy
1
Eastern Europe and Central Asia
1
Belgium
1
Portugal
1
Spain
1
Belarus
1
Sri Lanka
1
Bhutan
1
Authors & Publishers
Publication Years
Category
Policies & Guidelines HIV & TB
378
Studies & Reports
137
Guidelines
101
Capacity Building
72
HIV & STI
67
Statistics
60
Women & Child Health
59
COVID-19
53
TB
47
Policies
40
Drugs & Medical Equipment
26
Community Health
22
Pediatrics
20
Demograhic Health Surveys DHS
19
Paediatrics
15
Hepatitis
14
Reproductive Health
13
Communicable Diseases
9
Countries
9
Other
8
Information, Education and Communication (IEC)
7
Humanitarian Crisis
7
Women & Child Health
7
Non-communicable Diseases
7
Bacteriology
6
Humanitarian Aid
6
Maternal & Child Health
6
Communicable Diseases
6
Gynaecology & Obstetrics
6
Disease Prevention & Control
6
Clinical Training
5
Under-5 nutrition
5
General Guidelines
5
MPOX - Monkeypox
5
Chagas
5
Clinical Guidelines
5
Disabilities
5
Primary Health Care
5
Child Health
4
Vector Control
4
Community Health
4
Virology
4
Public Health
4
Health Systems
4
Neonatal Care
4
Family Planning
3
Buruli Ulcer
3
Dermatology
3
Training Manuals
3
Immunization
3
NTDs & Others
3
Maternal Health
3
Dengue
3
Leishmaniasis
3
Age & Elderly
3
Dental & Eye Care
2
Disaster Preparedness
2
Palliative Care
2
Vaccine-preventable Diseases
2
Diarrhoeal Disease/Cholera
2
Medical Devices & Equipment
2
Palliative Care
2
Quality Control & Assurance
2
General Guidelines
2
Digital Health
1
Rabies
1
Public Health
1
Helminthiasis
1
Onchocerciasis
1
Schistosomiasis
1
x MEDBOX Issue Brief & Annual Reports x
1
Monitoring & Evaluation
1
Cervical Cancer
1
IEC Material
1
NCD
1
Child protection
1
Yellow Fever
1
Mental Health
1
WASH
1
Diarrhoea
1
Respiratory Infections
1
Surgery & Anaesthesia
1
COPD/Asthma
1
Needs Assessment
1
Laboratory Quality Assurance
1
Malaria
1
Key Resources
1
Physiotherapy & Rehabilitation
1
Pharmacy & Technologies
1
Food Security & Nutrition
1
Toolboxes
Reports & Studies
109
Eastern Europe and central Asia
77
Children & Adolescents
60
Country specific documents
41
TB/HIV Coinfection
38
Treatment & Prevention
35
Clinical Aspects, Treatment & Prevention
31
Clinical Aspects
27
Detection & Diagnosis
27
Antiretroviral Treatment ART
27
HIV in Key Populations
27
Adults
25
Prevention & Control
23
Latin America & the Carribean
22
Treatment Guidelines HIV
20
General
20
Drug resistant TB
18
HIV testing & services
17
HIV
16
ART Drug Resistance
15
General Reports
15
Opportunistic Infections
15
Policies
14
Clinical Guidelines
14
Asia and Pacific
14
Policies and guidelines
14
Co-Morbidities (except TB)
14
Universal Health Coverage UHC and 90-90-90 Strategy
13
Women
13
Training
13
Children
12
TB/HIV
12
Prevention of mother-to-child transmission (PMTCT)
12
HIV and coinfection
12
Testing Guidelines
12
Laboratory
11
Inactivated COVID-19 Vaccines
11
HIV service delivery
11
Health Worker
10
Clinical Guidelines
10
Epidemiology
10
Access to treatment and laboratory
9
TB/HIV Global
9
Reports & Studies Children HIV
9
Policies & Strategies
8
Childhood TB
8
Transgender People
8
Handbooks & Manuals
8
Midwives
8
HIV &TB
8
TB & Prisoners
8
Research & Access
8
Lobby and Advocacy
8
Eastern and Southern Africa
8
Vaccines & Immunization
7
HIV testing & disclosure
7
Others
7
Global
7
Adherence
7
Discrimination & Stigma
7
Global Impact: Socio-economic, health services, TB & HIV
7
Biontech/Pfizer Comirnaty
7
Argentina
7
HIV surveillance
6
Ukraine
6
South Africa
6
IEC Materials
6
Reports
6
Russia
6
HIV and COVID-19
6
Nurses
6
MPOX - Monkeypox
6
Community Worker
6
Germany
6
HIV / AIDS
6
Male Circumcision
5
HIV in Children and mental health
5
TB & Drug Abuse
5
Laboratory
5
Drug resistance
5
Rwanda
5
Immunization Guidelines
5
Community Health Workers CHW
5
Colombia
5
Essential Medicines & Devices Lists
5
Pharmacy Practice
5
Clinical Aspects & Diagnostics
5
Studies & Reports
5
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
5
Prophylactic Treatment
5
Eastern Europe & Central Asia
5
Kenya
5
Prisoners
5
SEAR (South-east Asia Region)
5
Drugs
4
People who injecting Drugs
4
Clinical aspects
4
For Health Worker
4
COVID-19
4
Other Countries
4
Health Care In Conflict Settings
4
Vector control
4
Romania
4
General Aspects
4
Malawi
4
AmR (Region of Americas)
4
TB
4
Surveillance
3
Hepatitis
3
Men who have sex with men (MSM)
3
Children/Adolescents Mental Disorders
3
Country Guidelines
3
HIV / AIDS
3
Paediatrics
3
Moderna
3
Vaxzevria (Astra Zeneca)
3
Covaxin
3
Primary Care
3
Brazil
3
El Salvador
3
Booster Doses
3
Pediatrics
3
Women & Maternal Health
3
Clinical Aspects & Diagnostics
3
Nutrition
3
Others
3
Africa
2
Outbreak Prevention & Control
2
Behaviour Change/Life Skill Education
2
Biosafety
2
Prevention Guidelines
2
Children
2
Dengue
2
Namibia
2
Public Health
2
Orphans & vulnerable children
2
Communication & Training
2
TB
2
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
2
Prophylaxis
2
TB & Other Vulnerable Populations
2
Health & Refugee
2
Laboratory
2
Sex Worker
2
Ethiopia
2
Context & Facts, Travel Advice
2
COVID-19
2
Training, others
2
Protection of Vulnerable Groups
2
RCCE Guides & Manuals
2
TB/COVID-19
2
SARS-CoV-2 Variants
2
Health Promotion
2
Latin America
2
Overview
2
Peru
2
Chile
2
Essential Medicines
2
Zoonoses
2
MPOX - Monkeypox
2
Best Practice Examples
2
Chagas
2
Information & Education Material (IEC)
2
Overview, Studies & Reports
2
Onchocerciasis
2
General Information & Methodology
2
Prevention & Strategies
2
Prevention & Strategies
2
General
2
Substance Use Disorders & Addiction
2
Disease Prevention & Control
2
Tuberculosis
2
Uganda
2
Epidemiology
2
Universal Health Coverage & Primary Health Care
2
Disability Rights & Convention
1
Communication & Social Mobilisation
1
Gynaecology / Obstetrics
1
Assessment & Studies
1
HIV support organizations
1
Surveillance
1
Moldova
1
Azerbaijan
1
Policies & Strategies
1
Yellow Fever
1
Influenza Prevention & Control
1
Vaccination
1
Clinical Guidelines
1
Physiotherapy & Rehabilitation
1
Zambia
1
WPRO (Western Pacific Region)
1
South Sudan
1
Substance Use Disorders, Others
1
Humanitarian Settings
1
Germany
1
Inclusion
1
Latin America
1
Opoids
1
Wheelchair Service and Management
1
Sexually Transmitted Infections
1
Eastern Europe
1
Hepatitis
1
Physiotherapy & Rehabilitation
1
Latin America
1
Vaccination
1
SOPs
1
Mozambique
1
Human Rights
1
Epilepsy
1
Belarus
1
Key Resources
1
International
1
IEC Substance Use Disorders
1
Communication & Training
1
DR Congo
1
Treatment Guidelines
1
Clinical Aspects
1
Diagnostics & Laboratory Guidance
1
For General Public & Community
1
For Pregnant Women
1
Clinical Guidelines
1
Human Rights
1
Scientific & Research Studies
1
Gender Aspects
1
General Background
1
Oxygen Therapy
1
Essential Medicines & Medical Devices
1
Blood Supply
1
Tips & Best Practice Examples
1
Vaccination & Strategy
1
Access & Strategy
1
Communication Material
1
Long COVID/ Post-COVID Syndrome
1
Vector-based Vacines General
1
Johnson & Johnson
1
Others
1
Studies & Reports
1
Advocacy & Communication
1
Estonia
1
Ecuador
1
Pharmacy Management
1
Supply Chain & Store Management
1
Quality Assurance
1
Rational use of Medicine
1
Traditional & Herbal Medicines
1
Epilepsy
1
Guidelines & Manuals
1
Information Refugees Ukraine
1
General
1
MPOX -Monkeybox Prevention & Control
1
NTDs
1
Capacity Building & Resources
1
Capacity Building & Resources
1
Clinical Aspects & Diagnostics
1
Statistics & Facts
1
Statistics & Facts
1
Studies & Reports
1
Studies & Reports
1
Studies & Reports
1
Information & Education Material (IEC)
1
Leptospirosis
1
West and central Africa
1
General Information
1
Health Financing Toolbox
1
Clinical Aspects & Diagnosis
1
Studies & Reports
1
Studies & Reports
1
Studies & Reports
1
General
1
Clinical Guidelines
1
Botswana
1
Neurological Disorders
1
Ghana
1
General
1
Assistive devices & technologies
1
Protection
1
Assessment & Response
1
Regional Reports & Guidelines, others
1
Malnutrition
1
Policy
1
Regions
1
For Community Health Workers
1
Diarrhoea
1
Albania
1
Assessment & Response
1
Dengue Prevention & Control
1
Reproductive Health
1
Vision Loss & Blindness
1
Nigeria
1
Tobacco
1
Tajikistan
1
Western & Central Europe
1
South-east Asia Region
1
Paediatrics
1
Preparedness & Prevention
1
Global Health Financing
1
Depression
1
Meningitis & Encephalitis
1
Preparedness & Prevention
1
HIV & AIDS Treatment in Practice
Issue 203
Weekly epidemiological update on COVID-19, 28 September 2022
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th...
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
26 de abril del 2022. La Organización Panamericana de la Salud presenta estas consideraciones con el fin de apoyar la toma de decisiones relativa al manejo de pacientes con COVID-19 en la Región de las Américas. Las recomendaciones tienen en cuenta la evidencia más reciente, el estado de vacunac...
May 9, 2022.Since the onset of the COVID-19 pandemic, a large number of clinical trials have been planned and developed to assess the effectiveness and safety of various interventions that could prevent hospitalizations and progression to severe disease in people infected with SARS-CoV-2. Currently,...
Guía de tratamiento farmacológico y manejo deescenarios clínicos de casos de COVID-19 – enero 2022 Guía de tratamiento farmacológico y manejo deLeer más
Curr HIV/AIDS Rep. 2022; 19(1): 37–45.
Published online 2022 Jan 29. doi: 10.1007/s11904-021-00589-4.
COVID-19 has had an unprecedented impact on the cascade-of-care among PLWH in LAC. There is a need for
longitudinal studies that assess clinic implication of these pandemic interactions in LAC.
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons...
2nd edition. These guidelines include several notable changes from the first edition. For cutaneous leishmaniasis, ketoconazole has been removed from the list of treatment options; the number of Leishmania species for which there is strong evidence for the efficacy of miltefosine has increased from ...
This document provides an overview of key considerations for the provision of the HIV continuum of care in the context of displaced people from Ukraine in the EU/EEA. This document has two aims: firstly, to outline what is known of the Ukrainian HIV epidemic, and secondly, to use the HIV continuum o...
Campaña Nacional de Vacunación contra la COVID-19
La dosis de refuerzo está indicada una vez transcurridos los 4 meses (120 días) de la última dosis del esquema inicial y será con vacuna de plataforma ARNm: Pfizer-BioNTech pediátrica a partir de los 5 años o Moderna para uso pediátrico a partir de los 6 años.
La evidencia disponible a nivel internacional sobre el uso de un segundo refuerzo muestra una mayor duración de la respuesta inmune y una disminución de la internación y la mortalidad por COVID 19 en la población de adultos mayores y huéspedes inmunocomprometidos. Por otra parte, el personal de...
Desde el 2010, los Estados miembros de la Organización Panamericana
de la Salud (OPS) han asumido el compromiso de impulsar la eliminación de la transmisión materno infantil (ETMI) de la infección por el VIH y la sífilis. Estos compromisos se renovaron y ampliaron en el año 2016 mediante la...
first issued 18 August 2022
accessed on 22.08.2022
Plan nacional de salud mental 2021-2025
Las personas infectadas por el virus de la inmunodeficiencia humana (VIH) tienen
29 veces más probabilidades de enfermar de tuberculosis (TB) que las personas
sin VIH que viven en el mismo país. La TB es una de las principales causas de muerte entre las personas infectadas por el VIH: provoca ...
